{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001135",
    "licUnit": "1",
    "validDate": "2025-07-08 00:00:00.000",
    "issueDate": "2020-07-08 00:00:00.000",
    "oriIssueDate": "2020-07-08",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000113507",
    "prodNameC": "曲斯若凍晶注射劑150毫克",
    "prodNameE": "Trazimera Powder for Concentrate for Solution for infusion 150 mg",
    "indicationsName": [
        "一、應使用於下列HER2過度表現或HER2基因amplification之早期乳癌、轉移性乳癌病人：\r\n1. 早期乳癌（EBC）：\r\n(1) 經外科手術、化學療法（術前或術後）之輔助療法。\r\n(2) 以doxorubicin與cyclophosphamide治療，再合併paclitaxel或docetaxel之輔助療法。\r\n(3) 與docetaxel及carboplatin併用之輔助療法。\r\n(4) 術前與化學療法併用和術後之輔助療法使用於治療局部晚期（包括炎症）乳癌或腫瘤（直徑>2厘米）。\r\n2. 轉移性乳癌（MBC）：\r\n(1) 單獨使用於曾接受過一次（含）以上化學療法之轉移性乳癌；除非病人不適合使用anthracycline或taxane，否則先前之化學治療應至少包括anthracycline 或taxane。使用於荷爾蒙療法失敗之荷爾蒙受體陽性之病人，除非病人不適用荷爾蒙療法。\r\n(2) 與paclitaxel或docetaxel併用於未曾接受過化學療法之轉移性乳癌。\r\n(3) 與芳香環酶抑制劑併用於荷爾蒙受體陽性之轉移性乳癌。\r\n二、轉移性胃癌（MGC）：合併capecitabine（或5-fluorouracil）及cisplatin適用於未曾接受過化學治療之HER2過度表現轉移性胃腺癌（或胃食道接合處腺癌）的治療。"
    ],
    "does": "2243",
    "packageUnit": [
        {
            "packageSpec": "每玻璃小瓶150毫克；100支小瓶以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "D",
    "mainCategory": "D",
    "drBaseId": "D6530D43-7FCC-4617-B307-BE9BA4B2946E",
    "subCategory": [],
    "ingredientsDesc": [
        "TRASTUZUMAB"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "1D 須執行風險管理計畫",
        "1Q 不得輸入",
        "91 生物相似性藥品"
    ],
    "applicantName": "美商惠氏藥廠（亞洲）股份有限公司台灣分公司",
    "applicantAddr": "台北市信義區松仁路100號42、43樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2025-07-08",
    "licidNew": null,
    "licidOld": null,
    "manuImportDesc": "廠商未登錄資料",
    "licManuImport": "2",
    "factoryDtoList": [
        {
            "id": "0423580D-D70A-4B1B-9A6D-05D49EA1785E",
            "factoryCode": "1",
            "factoryName": "Pfizer Manufacturing Belgium NV",
            "factoryAddr": "Rijksweg 12 2870 Puurs-Sint-Amands Belgium",
            "factoryCompanyAddr": "",
            "countryCode": "BE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FBE8032000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "E896FDFC-BF49-474B-BFC9-0D53DE3F52D7",
            "factoryCode": "2",
            "factoryName": "BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG",
            "factoryAddr": "BIRKENDORFER STRASSE 65, 88397 BIBERACH AN DER RISS, GERMANY",
            "factoryCompanyAddr": "BINGER STRASSE 173, 55216 INGELHEIM AM RHEIN, GERMANY",
            "countryCode": "DE",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FDE0215000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "6EFEBC97-0ED1-4633-8D10-35D7687EFE99",
            "factoryCode": "2",
            "factoryName": "Pfizer Ireland Pharmaceuticals",
            "factoryAddr": "Grange Castle Business Park, Clondalkin, Dublin 22, Ireland",
            "factoryCompanyAddr": null,
            "countryCode": "IE",
            "processCode": [
                {
                    "value": "1K",
                    "name": "原料藥製造廠"
                }
            ],
            "processCodeStr": "1K;原料藥製造廠",
            "factoryKind": "M",
            "factoryNo": "FIE0045000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000500",
            "ingredientsName": "TRASTUZUMAB",
            "ingredientsDesc": "TRASTUZUMAB",
            "concentDesc": "",
            "concent": "150.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01FD01"
        }
    ],
    "licBaseId": "97E7292E-E767-4B00-BB58-8175FA96BC5D"
}